Harel Insurance Investments & Financial Services Ltd. Ayala Pharmaceuticals, Inc. Transaction History

Harel Insurance Investments & Financial Services Ltd.

$5.8 Billion
Q3 2024

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 19, 2022	SELL	$0.99 - $4.15 $581 - $2,436	-587 Reduced 0.03%	2,153,273 $2.35 Million
Q1 2022 May 03, 2022	BUY	$3.5 - $9.11 $742 - $1,931	212 Added 0.01%	2,153,860 $8.57 Million
Q4 2021 Feb 07, 2022	BUY	$8.32 - $12.45 $17.9 Million - $26.8 Million	2,153,118 Added 406248.69%	2,153,648 $18.3 Million
Q3 2021 Oct 25, 2021	BUY	$8.13 - $14.09 $585 - $1,014	72 Added 15.72%	530 $6,000
Q2 2021 Jul 26, 2021	BUY	$9.2 - $11.3 $4,213 - $5,175	458 New	458 $5,000

Others Institutions Holding AYLA

# of Institutions

Shares Held

Call Options Held

Put Options Held

Concourse Financial Group Securities, Inc. Birmingham, AL

0
Shares

$0
0.0% of portfolio

View Full List

About Ayala Pharmaceuticals, Inc.

Ticker AYLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 14,833,300
Description
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. The company's lead product candidate is AL101, a potent, selective, and injectable small molecule gamma secretase inhibitor (GSI) that is in Phase II clinic...

More about AYLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Harel Insurance Investments & Financial Services Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Harel Insurance Investments & Financial Services Ltd. with notifications on news.

Account